Haleon plc (NYSE:HLN) Short Interest Update

Haleon plc (NYSE:HLN) was the recipient of a significant decrease in short interest in April. As of April 15th, there was short interest totalling 23,970,000 shares, a decrease of 5.5% from the March 31st total of 25,360,000 shares. Currently, 0.5% of the company’s shares are sold short. Based on an average daily volume of 5,710,000 shares, the short-interest ratio is currently 4.2 days.

Institutional Investors Weigh In On Haleon

Several large investors have recently made changes to their positions in the stock. FMR LLC increased its position in shares of Haleon by 22.2% during the third quarter. FMR LLC now owns 53,951,936 shares of the company’s stock worth $449,420,000 after acquiring an additional 9,812,040 shares in the last quarter. Clearbridge Investments LLC grew its position in Haleon by 2.4% in the fourth quarter. Clearbridge Investments LLC now owns 26,581,902 shares of the company’s stock valued at $218,769,000 after purchasing an additional 612,400 shares in the last quarter. Wellington Management Group LLP grew its position in Haleon by 164.6% in the fourth quarter. Wellington Management Group LLP now owns 13,542,346 shares of the company’s stock valued at $111,454,000 after purchasing an additional 8,423,475 shares in the last quarter. Douglas Lane & Associates LLC grew its position in Haleon by 2.1% in the first quarter. Douglas Lane & Associates LLC now owns 8,401,876 shares of the company’s stock valued at $71,332,000 after purchasing an additional 175,082 shares in the last quarter. Finally, Envestnet Asset Management Inc. grew its position in Haleon by 121.2% in the third quarter. Envestnet Asset Management Inc. now owns 5,931,187 shares of the company’s stock valued at $49,407,000 after purchasing an additional 3,249,517 shares in the last quarter. Institutional investors own 6.67% of the company’s stock.

Analysts Set New Price Targets

Several equities research analysts have commented on HLN shares. HSBC started coverage on shares of Haleon in a research note on Wednesday, April 17th. They issued a “buy” rating for the company. Argus reaffirmed a “buy” rating on shares of Haleon in a research note on Tuesday, March 26th. Two investment analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy”.

Haleon Stock Down 2.2 %

Shares of HLN stock opened at $8.34 on Thursday. The firm has a fifty day moving average of $8.34 and a 200-day moving average of $8.29. The company has a quick ratio of 0.73, a current ratio of 1.04 and a debt-to-equity ratio of 0.53. Haleon has a 12-month low of $7.70 and a 12-month high of $8.98. The company has a market capitalization of $38.08 billion, a price-to-earnings ratio of 29.79, a P/E/G ratio of 2.23 and a beta of 0.28.

Haleon Dividend Announcement

The business also recently disclosed a semi-annual dividend, which will be paid on Thursday, May 16th. Stockholders of record on Friday, March 15th will be given a dividend of $0.1064 per share. This represents a dividend yield of 1.8%. The ex-dividend date is Thursday, March 14th. Haleon’s dividend payout ratio is 75.00%.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.